JL-13

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameJL-13

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine D4 receptor antagonistsSerotonin 2 (5-HT2) receptor antagonists

TargetsDopamine D4 receptorSerotonin 2 (5-HT2) receptor

Therapy Area/IndicationsPsychotic Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTherabel Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTherabel Pharma

Active IndicationsN/A

Inactive IndicationsPsychotic Disorders

ATC CodeN/A